Keywords: Strativa, FDA, USA, Zuplenz, Par Pharma, MonoSol Rx, milestone

FDA finally approves Strativa’s Zuplenz

Article | 05 July 2010

Print This

Strativa Pharmaceuticals, a unit of Par Pharmaceuticals, announced on Friday that the US Food and Drug Administration had approved Zuplenz ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in